ArticlePoultry science2026
Residue depletion and withdrawal period determination of fluralaner in edible tissues and eggs following oral administration in laying Hens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the residue depletion kinetics and establish the withdrawal period of fluralaner in chickens and eggs, a sensitive and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the quantitative determination of fluralaner residues in edible chicken tissues and eggs. Furthere more, fifty healthy Hy-Line Brown laying hens were selected and received fluralaner solution via drinking water at a dosage of 0.5 mg/kg body weight on the 1st day and 8th day. At 7 days after the final administration, fluralaner residues in all edible tissues declined to levels below their respective maximum residue limits (MRLs). Using WT1.4 software and calculations based on the 95 % confidence interval, the withdrawal periods for fluralaner in muscle, liver, kidney, skin/fat were 12.19, 8.06 10.67 and 4.60 days, respectively. On day 7 after the final administration, the maximum observed fluralaner residue concentration in eggs was 890.72 µg/kg. This level was below the established MRL for eggs (1300 µg/kg) as stipulated by both the Ministry of Agriculture and Rural Affairs of China and the European Union. Moreover, the fluralaner concentration at each time point in eggs remained below 1300 µg/kg at 95 % confidence interval. Considering inter-individual variability, age related metabolic differences, and in reference to the approved withdrawal and egg-discard periods of the originator formulation Exzolt®, a withdrawal period of 14 days was established for the self-prepared fluralaner solution in chickens, while the egg-discard period was determined to be 0 days. Current study provides a scientific and regulatory basis for the rational use of fluralaner in laying hens and supports the establishment of an appropriate withdrawal period and egg-discard strategy in layer production systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.